OR
CC icon

Olympiad Research’s Chemours CC Stock Holding History

Olympiad Research’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,261
Closed -$117K – 218
2025
Q2 		$117K Buy
+10,261
New +$116K 0.19% 163
2020
Q4 		– Sell
-10,734
Closed -$224K – 154
2020
Q3 		$224K Sell
10,734
-1,190
-10% -$23K 0.11% 254
2020
Q2 		$183K Buy
+11,924
New +$151K 0.13% 230

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Olympiad Research's CC Position: Q3 2025 in Review

Olympiad Research sold out of Chemours (CC) in Q3 2025, closing a stake of 10,261 shares — an estimated $117K sold.

Olympiad Research first reported a position in CC in Q2 2020 and held it in 3 quarters. The position peaked at $224K in Q3 2020. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Olympiad Research reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
  • Olympiad Research sold 10,261 Chemours shares in Q3 2025, an estimated $117K.
  • Olympiad Research first reported a position in Chemours in Q2 2020 and held it in 3 quarters.
  • Olympiad Research's Chemours position peaked at $224K in Q3 2020.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Olympiad Research's 13F filing for Q3 2025, filed 30 Oct 2025.